Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Premedication before neuraxial anesthesia in pre-eclamptic patients undergoing caesarean section
PACTR202610704393755Phase 4Completed
- Sponsor
- Ain Shams University Hospitals
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of midazolam and thiopental in preeclampsia, sponsored by Ain Shams University Hospitals. Primary endpoint: Maternal hemodynamic stability during neuraxial anesthesia. Started Oct 2024; status: completed.
02
Drugs
midazolamthiopental
03
Conditions
preeclampsia
Beyond the preview
Go deeper on PACTR202610704393755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202610704393755.